Oncolytic Vaccinia Virus Expressing HSP70 shRNA Exerts Anti-Tumor Effects in Human Ovarian Cancer via Triggering the Autophagy–ROS Feedback Loop and Immune Activation
Viruses · 27.10.2025 · 17 (11) · 1423
DOI: 10.3390/v17111423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 27.10.2025. Verfasst von Zheqi Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. Hauptthemen laut MEDLINE: HSP70 Heat-Shock Proteins, Ovarian Neoplasms, Vaccinia virus, Oncolytic Viruses. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Heat shock protein 70 (HSP70) represents a promising target for cancer therapy. Oncolytic vaccinia virus (oncoVV) mediates tumor regression through direct oncolysis and immune activation. However, the anti-tumor potential of HSP70-silenced oncoVV (oncoVV-shHSP70) remains unexplored. Here, we demonstrate that oncoVV-shHSP70 achieves superior tumor regression in ovarian cancer models (cell lines, immunodeficient mice and humanized mice) via dual mechanisms including enhancing apoptosis, autophagy flux, ROS generation, and immune reprogramming. Notably, we found that oncoVV-shHSP70 triggers an autophagy–ROS feedback loop that amplifies viral replication and pro-inflammatory cytokine expression. Crucially, in humanized mice, oncoVV-shHSP70 induced spatial redistribution of cytotoxic T cells, expanding tumor-infiltrating hCD8+hGZMB+ populations. These findings position oncoVV-shHSP70 as a promising viro-immunotherapy that co-opts HSP70 silencing to potentiate both direct oncolysis and anti-tumor immunity, providing a preclinical rationale for viro-immunotherapy in solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
ORCID-Profile: Yanrong Zhou
Förderung
- National Natural Science Foundation of China
- the National Natural Science Foundation of China
Zitieren
APA
Cai, Z., Hong, Z., Zhang, G., Zhu, T., Zhou, Y., Ye, T., Li, G., & Chen, K. (2025). Oncolytic Vaccinia Virus Expressing HSP70 shRNA Exerts Anti-Tumor Effects in Human Ovarian Cancer via Triggering the Autophagy–ROS Feedback Loop and Immune Activation. Viruses, 17(11), 1423. https://doi.org/10.3390/v17111423
Vancouver
Cai Z, Hong Z, Zhang G, Zhu T, Zhou Y, Ye T, et al. Oncolytic Vaccinia Virus Expressing HSP70 shRNA Exerts Anti-Tumor Effects in Human Ovarian Cancer via Triggering the Autophagy–ROS Feedback Loop and Immune Activation. Viruses. 2025;17(11):1423. doi:10.3390/v17111423
BibTeX
@article{Cai2025,
author = {Cai, Zheqi and Hong, Zhiyun and Zhang, Guohui and Zhu, Tinwei and Zhou, Yanrong and Ye, Ting and Li, Gongchu and Chen, Kan},
title = {Oncolytic Vaccinia Virus Expressing HSP70 shRNA Exerts Anti-Tumor Effects in Human Ovarian Cancer via Triggering the Autophagy–ROS Feedback Loop and Immune Activation},
journal = {Viruses},
year = {2025},
volume = {17},
number = {11},
pages = {1423},
doi = {10.3390/v17111423}
}
EUVIMED